A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Plaque Psoriasis
Public ClinicalTrials.gov record NCT05600036. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Moderate to Severe Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multi-center, randomized, double-blind, placebo-controlled study in patients with moderate to severe plaque psoriasis.
Study identification
- NCT ID
- NCT05600036
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 228 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 27, 2022 (Actual)
- Primary completion
- Jun 29, 2023 (Actual)
- Completion
- Jul 25, 2023 (Actual)
- Last update posted
- Jun 18, 2025
2022 – 2023
United States locations
- U.S. sites
- 38
- U.S. states
- 21
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigator Site #1029 | Birmingham | Alabama | 35205 | — |
| Investigator Site # 1001 | Phoenix | Arizona | 85032 | — |
| Investigator Site #1023 | Rogers | Arkansas | 72758 | — |
| Investigator Site #1021 | Encinitas | California | 92024 | — |
| Investigator Site # 1008 | Fremont | California | 94538 | — |
| Investigator Site #1024 | Los Angeles | California | 90033 | — |
| Investigator Site # 1018 | Los Angeles | California | 90045 | — |
| Investigator Site #1016 | San Diego | California | 92123 | — |
| Investigator Site # 1007 | Santa Monica | California | 90404 | — |
| Investigator Site # 1002 | Sherman Oaks | California | 91403 | — |
| Investigator Site #1039 | Brandon | Florida | 33511 | — |
| Investigator Site #1013 | Brandon | Florida | 33756 | — |
| Investigator Site #1030 | Fort Lauderdale | Florida | 33308 | — |
| Investigator Site #1025 | Hialeah | Florida | 33012 | — |
| Investigator Site #1028 | Miami | Florida | 33175 | — |
| Investigator Site #1042 | Tampa | Florida | 33613 | — |
| Investigator Site #1035 | Macon | Georgia | 31217 | — |
| Investigator Site #1043 | Sandy Springs | Georgia | 30328 | — |
| Investigator Site # 1005 | Rolling Meadows | Illinois | 60008 | — |
| Investigator Site #1011 | Indianapolis | Indiana | 46250 | — |
| Investigator Site #1027 | South Bend | Indiana | 46617 | — |
| Investigator Site #1036 | Overland Park | Kansas | 66210 | — |
| Investigator Site #1034 | Louisville | Kentucky | 40241 | — |
| Investigator Site #1017 | Owensboro | Kentucky | 42303 | — |
| Investigator Site #1026 | Rockville | Maryland | 20850 | — |
| Investigator Site #1009 | Bay City | Michigan | 48706 | — |
| Investigator Site # 1010 | Clarkston | Michigan | 48346 | — |
| Investigator Site #1038 | Warren | Michigan | 48088 | — |
| Investigator Site #1031 | New Brighton | Minnesota | 55112 | — |
| Investigator Site #1014 | Las Vegas | Nevada | 89148 | — |
| Investigator Site #1037 | Portsmouth | New Hampshire | 03801 | — |
| Investigator Site #1033 | Oklahoma City | Oklahoma | 73170 | — |
| Investigator Site # 1019 | Portland | Oregon | 97223 | — |
| Investigator Site #1022 | Philadelphia | Pennsylvania | 19103 | — |
| Investigator Site #1012 | Rapid City | South Dakota | 57702 | — |
| Investigator Site # 1015 | Houston | Texas | 77056 | — |
| Investigator Site #1006 | San Antonio | Texas | 78213 | — |
| Investigator Site #1041 | South Jordan | Utah | 84095 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05600036, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 18, 2025 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05600036 live on ClinicalTrials.gov.